Registry for Mycobacterial infections
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- A registry can be used to educate healthcare providers about mycobacterial infections, improving awareness and understanding of these infections among clinicians. Data from the registry can help in developing personalized treatment plans based on the specific mycobacterial species and patient demographics.
研究概览
简要总结
In order to allow for the use of the information derived from this clinical Study, there is an obligation on the part of the Study personnel to provide Suvarna Swasthya Research Centre or designee with complete test results and all data developed in this Study, as well as direct access to source data/documents for Study-related monitoring, audits, Independent Ethics
Committee/Institutional Review Board (IEC/IRB) review, and regulatory inspection. All records that support the final case reports of this Study must be retained in the files of the Study for a minimum of 15 years after the completion of the Study. No documents will be destroyed without prior written agreement between Suvarna Swasthya Research Centre and the Study personnel.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 30.00 Month(s) 至 90.00 Year(s)（—）
- 性别
- All
入选标准
- •Individuals with signs and symptoms of Mycobacterial infection
- •Both males and females and transgender population are eligible for the study
- •Any age group subjects are eligible for the study.
- •All participants must be able to provide consent for themselves or have a parent/ guardian who can provide parental permission or have an authorized legal representative who can provide consent.
排除标准
- •1.Hostile or vulnerable patient group (e.g. prisoners and mentally retarded).
- •2.Patients who are unable to understand the study protocol or are unable to give informed consent or have no legal representative.
结局指标
主要结局
A registry can be used to educate healthcare providers about mycobacterial infections, improving awareness and understanding of these infections among clinicians. Data from the registry can help in developing personalized treatment plans based on the specific mycobacterial species and patient demographics.
时间窗: Ten years
次要结局
- For patients in whom, the standard therapy has failed, addition of Moxifloxacin could improve treatment outcomes. a clinical and laboratory registry for mycobacterial infections can significantly improve the diagnosis, treatment, and management of these infections, ultimately enhancing patient outcomes and public health in India
研究者
Vijay V Yeldandi
SSRC Health Clinics